FXYD Domain Containing Ion Transport Regulator 6 (FXYD6), also known as phosphohippolin, is a member of the FXYD family of proteins, which are known to be regulators of the Na, K-ATPase ion pumps. These pumps are crucial for maintaining the electrochemical gradients of sodium and potassium ions across the plasma membrane, which is essential for various cellular processes, including nerve impulse transmission and muscle contraction.FXYD6 is primarily expressed in the brain, particularly in the hippocampus, a region essential for learning and memory. It modulates the kinetics of the Na, K-ATPase ion pump, adjusting the balance of ions in neurons and influencing their excitability.
Emerging research has linked FXYD6 to several neurological and psychiatric conditions. Variations in the FXYD6 gene have been associated with susceptibility to schizophrenia, a severe mental disorder characterized by hallucinations, delusions, and cognitive deficits. However, the exact mechanisms underlying this association remain unclear.In addition, FXYD6 has been implicated in human tinnitus, a condition characterized by the perception of noise or ringing in the ears. A mutation in the FXYD6 gene was identified in a family with a history of tinnitus, suggesting a potential role in auditory processing.In summary, FXYD6 is a regulator of ion transport essential for the proper functioning of neurons. Its primary expression in the brain and associations with conditions like schizophrenia and tinnitus underline its relevance in neurobiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
A cardiac glycoside that inhibits Na+/K+-ATPase. It may indirectly affect FXYD6 by altering the pump's regulation. | ||||||
Bufalin | 465-21-4 | sc-200136 sc-200136A sc-200136B sc-200136C | 10 mg 25 mg 50 mg 100 mg | $99.00 $204.00 $341.00 $544.00 | 5 | |
A cardiac glycoside similar to ouabain, known to inhibit Na+/K+-ATPase, possibly influencing FXYD6 function. | ||||||
Norgestimate | 35189-28-7 | sc-219404C sc-219404 sc-219404A sc-219404B | 5 mg 10 mg 25 mg 50 mg | $189.00 $250.00 $490.00 $821.00 | 1 | |
A cardiac glycoside, inhibits Na+/K+-ATPase, may influence FXYD6 activity indirectly. | ||||||
Digitoxin | 71-63-6 | sc-207577 sc-207577A sc-207577B sc-207577C sc-207577D | 250 mg 500 mg 1 g 5 g 10 g | $112.00 $186.00 $319.00 $1102.00 $2040.00 | 2 | |
A cardiac glycoside, inhibits Na+/K+-ATPase, which might affect FXYD6 function. | ||||||